ORIGINAL RESEARCH article
Front. Public Health
Sec. Public Health Policy
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1652174
Study on inpatient expenses and cost control strategies for breast cancer patients based on Diagnosis-Intervention Packet
Provisionally accepted
- Henan Cancer Hospital Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Aim: To provide reference information for reducing disease burden and promoting medical service. The inpatient expenses of breast cancer patients in a top-three public hospital in Zhengzhou under the background of Diagnosis-Intervention Packet (DIP) payment reform were analyzed, and corresponding cost control strategies were proposed. Methods: In this study, 4590 patients (3311 before reform and 1279 after reform) were finally included in this study. Student's t-test was used to compare the means of two samples. Chi-square test was used for the comparison of rates. The influencing factors of profit of the patients after reform were analyzed by binary logistic regression. Results: Post-reform data revealed a significant reduction in medication costs and examination fees (P < 0.05), contributing to lower overall hospitalization expenses. The profit ratio of c50.9_86 (c50.9_86.0603: Chemotherapy pump implantation surgery for unspecified breast malignant tumors) group was the highest, about 63.2%, and the loss ratio of c50.9_99 (c50.9_99.2503: Intravenous injection of chemotherapy drugs for unspecified breast malignant tumors) group was the highest, about 66.7%. The length of hospital stay was the protective factor of profit, whereas the score of disease and employee insurance were the risk factors of profit. Conclusion: The DIP reform significantly reduced medication costs outside of surgery. Under the DIP payment mode reform policy, hospitals should strengthen the awareness of cost control and reduce medical costs, optimize the score of disease and group setting, pay attention to optimize disease structure and ensure fair access to treatment for patients.
Keywords: Medical service, DIP, breast cancer, inpatient expenses, Risk factors
Received: 23 Jun 2025; Accepted: 09 Oct 2025.
Copyright: © 2025 Yue, Pan and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Wujun Chen, 1360011901@qq.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.